{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:24:03Z","timestamp":1790663043913,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.rdc.2016.01.011","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T11:02:28Z","timestamp":1458212548000},"page":"285-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Patient-Reported Outcomes in Axial Spondyloarthritis"],"prefix":"10.1016","volume":"42","author":[{"given":"Derek T.","family":"Nhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liron","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2016.01.011_bib1","first-page":"126","article-title":"A\u00a0controlled study of flufenamic acid\u00a0in ankylosing spondylitis. A preliminary report","volume":"Suppl","author":"Simpson","year":"1966","journal-title":"Ann Phys Med"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.011_bib2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jama.1970.03170180151027","article-title":"Ernst Adolph G.G. von Str\u00fcmpell (1852-1925). Marie-Stmpell spondylitis","volume":"212","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2016.01.011_bib3","doi-asserted-by":"crossref","unstructured":"Ebringer A. History of the origin of ankylosing spondylitis. Springer-Verlag (London): Ankylosing spondylitis and klebsiella. 2013. p. 7\u201313. Available at: http:\/\/www.springer.com\/us\/book\/9781447142997.","DOI":"10.1007\/978-1-4471-4300-0_2"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.011_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00005792-197409000-00002","article-title":"Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome","volume":"53","author":"Moll","year":"1974","journal-title":"Medicine (Baltimore)"},{"issue":"24","key":"10.1016\/j.rdc.2016.01.011_bib5","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.1977.03270510035017","article-title":"Clinical history as a screening test for ankylosing spondylitis","volume":"237","author":"Calin","year":"1977","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.011_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2016.01.011_bib7","first-page":"85","article-title":"Criteria of the classification of spondylarthropathies","volume":"57","author":"Amor","year":"1990","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"10","key":"10.1016\/j.rdc.2016.01.011_bib8","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.011_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.011_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/rheumatology\/keh549","article-title":"Patient-assessed health in ankylosing spondylitis: a structured review","volume":"44","author":"Haywood","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.011_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.62.1.20","article-title":"Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis","volume":"62","author":"Doward","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.rdc.2016.01.011_bib12","first-page":"2281","article-title":"A\u00a0new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index","volume":"21","author":"Calin","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl 11","key":"10.1016\/j.rdc.2016.01.011_bib13","first-page":"S47","volume":"63","author":"Zochling","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.011_bib14","first-page":"1056","article-title":"Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review","volume":"28","author":"Boonen","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2016.01.011_bib15","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/rheumatology\/kep190","article-title":"Reproducibility of performance measures of physical function based on the BASFI, in ankylosing spondylitis","volume":"48","author":"van Weely","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.011_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2005.041137","article-title":"ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"65","author":"Zochling","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.011_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K","article-title":"Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug","volume":"44","author":"Dougados","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2016.01.011_bib18","first-page":"2286","article-title":"A\u00a0new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2016.01.011_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ncprheum0591","article-title":"The assessment of ankylosing spondylitis in clinical practice","volume":"3","author":"Sengupta","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.011_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/35.1.66","article-title":"The bath ankylosing spondylitis patient global score (BAS-G)","volume":"35","author":"Jones","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.011_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2016.01.011_bib22","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3899\/jrheum.110279","article-title":"Endorsement of definitions of disease activity states and improvement scores for the ankylosing spondylitis disease activity score: results from OMERACT 10","volume":"38","author":"Machado","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2016.01.011_bib23","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","article-title":"ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis","volume":"68","author":"van der Heijde","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"10.1016\/j.rdc.2016.01.011_bib24","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2016.01.011_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7525-5-7","article-title":"Translation and validation of non-English versions of the ankylosing spondylitis quality of life (ASQOL) questionnaire","volume":"5","author":"Doward","year":"2007","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"10.1016\/j.rdc.2016.01.011_bib26","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/rheumatology\/41.11.1295","article-title":"Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness","volume":"41","author":"Haywood","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.011_bib27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/rheumatology\/keh169","article-title":"Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness","volume":"43","author":"Haywood","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.011_bib28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.20539","article-title":"Impact of fatigue on health-related quality of life in rheumatoid arthritis","volume":"51","author":"Rupp","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2016.01.011_bib29","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10067-013-2445-6","article-title":"Fatigue in patients with spondyloarthritis associates with disease activity, quality of life and inflammatory bowel symptoms","volume":"33","author":"Stebbings","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2016.01.011_bib30","first-page":"946","article-title":"A\u00a0modification of the health assessment questionnaire for the spondyloarthropathies","volume":"17","author":"Daltroy","year":"1990","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2016.01.011_bib31","first-page":"1694","article-title":"Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index","volume":"21","author":"Jenkinson","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.01.011_bib32","first-page":"407","article-title":"An update on the Bath Ankylosing Spondylitis Disease Activity and Functional Indices (BASDAI, BASFI): excellent Cronbach's alpha scores","volume":"23","author":"Biasi","year":"1996","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2016.01.011_bib33","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s10067-007-0573-6","article-title":"Evaluation of internal consistency and re-test reliability of Bath Ankylosing Spondylitis Indices in a large cohort of adult and juvenile spondylitis patients in Taiwan","volume":"26","author":"Wei","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.011_bib34","first-page":"979","article-title":"Measuring disability in ankylosing spondylitis: comparison of Bath Ankylosing Spondylitis Functional Index with revised Leeds Disability Questionnaire","volume":"29","author":"Eyres","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2016.01.011_bib35","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/annrheumdis-2012-202976","article-title":"Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme","volume":"73","author":"Fernandez-Espartero","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.011_bib36","first-page":"961","article-title":"A\u00a0comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis","volume":"26","author":"Spoorenberg","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"18","key":"10.1016\/j.rdc.2016.01.011_bib37","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha","volume":"346","author":"Gorman","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.011_bib38","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/ard.2008.091793","article-title":"Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine","volume":"68","author":"Landewe","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.011_bib39","first-page":"218","article-title":"Evaluation of a German version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados Functional Index (D-FI)","volume":"58","author":"Ruof","year":"1999","journal-title":"Z\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2016.01.011_bib40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00296-004-0565-7","article-title":"Evaluation of the Turkish version of the Dougados Functional Index in ankylosing spondylitis","volume":"25","author":"Ozer","year":"2005","journal-title":"Rheumatol Int"},{"issue":"9","key":"10.1016\/j.rdc.2016.01.011_bib41","first-page":"1959","article-title":"Comparative responsiveness of 3 functional indices in ankylosing spondylitis","volume":"26","author":"Ruof","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2016.01.011_bib42","first-page":"121","article-title":"Validity and sensitivity to change of spondylitis-specific measures of functional disability","volume":"26","author":"Ward","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.011_bib43","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00296-011-1795-0","article-title":"Validity and reliability of the Turkish version of the health assessment questionnaire for the spondyloarthropathies","volume":"32","author":"Ozcan","year":"2012","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.rdc.2016.01.011_bib44","first-page":"1609","article-title":"A\u00a0new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI)","volume":"22","author":"Jones","year":"1995","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.011_bib45","first-page":"264","article-title":"Adaption and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany","volume":"62","author":"Brandt","year":"2003","journal-title":"Z\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2016.01.011_bib46","first-page":"1954","article-title":"Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy","volume":"24","author":"Claudepierre","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2016.01.011_bib47","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/rheumatology\/38.9.878","article-title":"Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?","volume":"38","author":"Calin","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.011_bib48","first-page":"451","volume":"21","author":"Cardiel","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2016.01.011_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/030097499750042281","article-title":"The Swedish version of the Bath Ankylosing Spondylitis Disease Activity Index. Reliability and validity","volume":"111","author":"Waldner","year":"1999","journal-title":"Scand J Rheumatol Suppl"},{"issue":"6","key":"10.1016\/j.rdc.2016.01.011_bib50","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.2009.111187","article-title":"Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors","volume":"69","author":"Pedersen","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2016.01.011_bib51","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1756-185X.2010.01554.x","article-title":"The ankylosing spondylitis quality of life questionnaire: validation in a New Zealand cohort","volume":"13","author":"Jenks","year":"2010","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2016.01.011_bib52","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00296-006-0267-4","article-title":"Evaluation of quality of life using ASQoL questionnaire in patients with ankylosing spondylitis in a Chinese population","volume":"27","author":"Zhao","year":"2007","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.rdc.2016.01.011_bib53","first-page":"379","article-title":"Development and validation of the French ASQoL questionnaire","volume":"28","author":"Pham","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2016.01.011_bib54","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/ard.62.9.817","article-title":"International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis","volume":"62","author":"Braun","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2016.01.011_bib55","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/rheumatology\/keh669","article-title":"BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology","volume":"44","author":"Keat","year":"2005","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:13:27Z","timestamp":1760181207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X16000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0889857X16000120"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2016.01.011","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-Reported Outcomes in Axial Spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2016.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}